Stentys announced the publication of the results of the APPOSITION I clinical study in the September issue of the medical journal EuroIntervention. The study showed that the Stentys Self-Apposing stent enabled the perfect apposition of these stents when treating patients with acute myocardial infarction.
The self-apposing feature of the Stentys stent ensures optimal apposition during thrombus and vessel spasm relief in the critical initial hours and days after an acute myocardial infarction procedure, thereby avoiding malapposition.
“We continue to be very pleased with the results of the Stentys Self-Apposing stent when treating acute myocardial infarction,” said Giovanni Amoroso, OLVG Hospital, Amsterdam, The Netherlands, and lead author of the article. “During the six-month follow-up period of the APPOSITION I study, there was no death, no stent thrombosis or reoccurrence of myocardial infarction, with revascularisation rates comparable to that of conventional stents.”
